Pruvanserin (INN; USAN; developmental code names EMD-281,014, LY-2422347) is a selective serotonin 5-HT2A receptor antagonist which was under development by Eli Lilly and Company for the treatment of insomnia.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.